FDA approves Xtoro to treat swimmer’s ear

The U.S. Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer’s ear.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427274.htm

Source: Food and Drug Administration - December 17, 2014 Category: American Health Source Type: news

More News: American Health | Food and Drug Administration (FDA) | Otitis | Otitis Externa (Swimmer's Ear)